Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Mind Medicine Inc shares valued at $73,623 were sold by Karlin Daniel on Dec 26 ’25. At $13.15 per share, Karlin Daniel sold 5,600 shares. The insider’s holdings dropped to 425,025 shares worth approximately $5.96 million following the completion of this transaction.
Also, Barrow Robert sold 25,791 shares, netting a total of over 339,072 in proceeds. Following the sale of shares at $13.15 each, the insider now holds 778,477 shares.
Before that, Sullivan Mark had sold 11,276 shares from its account. In a trade valued at $148,244, the Chief Legal Officer traded Mind Medicine Inc shares for $13.15 each. Upon closing the transaction, the insider’s holdings decreased to 11,276 shares, worth approximately $3.96 million.
As published in their initiating research note from Needham on October 13, 2025, Mind Medicine Inc [MNMD] has been a Buy and the price target has been revised to $28. As of January 28, 2025, Evercore ISI has initiated its “an Outperform” rating for MNMD. Earlier on December 20, 2024, Chardan Capital Markets initiated its rating. Their recommendation was “a Buy” for MNMD stock.
Analyzing MNMD Stock Performance
On last trading session, Mind Medicine Inc [NASDAQ: MNMD] rose 3.85% to $14.03. The stock’s lowest price that day was $13.52, but it reached a high of $14.16 in the same session. During the last five days, there has been a surge of approximately 8.34%. Over the course of the year, Mind Medicine Inc shares have jumped approximately 95.40%. Shares of the company reached a 52-week high of $14.81 on 01/05/26 and a 52-week low of $13.06 on 01/06/26.
Support And Resistance Levels for Mind Medicine Inc (MNMD)
According to the 24-hour chart, there is a support level at 13.65, which, if violated, would cause prices to drop to 13.26. In the upper region, resistance lies at 14.29. The next price resistance is at 14.54. RSI (Relative Strength Index) is 62.06 on the 14-day chart, showing neutral technical sentiment.
Is Mind Medicine Inc subject to short interest?
Stocks of Mind Medicine Inc saw a sharp rise in short interest on 2025-12-15 jumping by 0.32 million shares to 12.61 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 12.29 million shares. A jump of 2.58% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.66 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.66.
Which companies own the most shares of Mind Medicine Inc (MNMD)?
In terms of Mind Medicine Inc share price expectations, FactSet research, analysts set an average price target of 28 in the next 12 months, up nearly 107.25% from the previous closing price of $13.51. Analysts anticipate Mind Medicine Inc stock to reach 28 by 2026, with the lowest price target being 28. In spite of this, 2 analysts ranked Mind Medicine Inc stock as Buy at the end of 2026. On October 14, 2024, Leerink Partners assigned a price target of “an Outperform” to the stock and resumed coverage with a $20.
